SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-021426
Filing Date
2021-04-28
Accepted
2021-04-28 16:54:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ntla-defa14a_20210623.htm DEFA14A 27420
2 GRAPHIC gdfxr3fx4cm0000002.jpg GRAPHIC 150282
3 GRAPHIC gdfxr3fx4cm0000001.jpg GRAPHIC 208653
  Complete submission text file 0001564590-21-021426.txt   522694
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37766 | Film No.: 21865082
SIC: 2835 In Vitro & In Vivo Diagnostic Substances